India’s food regulator FSSAI has initiated legal action against Nestle India, citing alleged violations linked to infant and young child milk powder products.
Under food safety and standards rules, promotions that could boost the sale of foods meant for infants and young children are subject to strict controls and monitoring. As part of this oversight, FSSAI reviewed three Nestle products—NAN Excella Pro Stage 1, Lactogen Pro 1, and Palo Up Formula—along with their advertisements.
According to the regulator, the advertisement for NAN Excella Pro Stage 1 carried claims referencing “5 HMOs” and “whey protein”. FSSAI sought an explanation from the company and said the advertising content was not in line with the applicable rules for infant foods.
FSSAI also flagged the Lactogen Pro 1 advertisement for stating that whey protein is “easy to digest”, and asked Nestle India to clarify the claim.
Separately, Palo Up Formula, meant for children who consume complementary foods, was tested in a laboratory. FSSAI said the level of biotin (vitamin B7) did not match the prescribed standard, and the finding was confirmed in a re-test. The regulator said it has registered three separate cases—two related to advertising claims and one based on the lab test result.
